DE1643310A1
(de)
|
1966-12-29 |
1971-06-03 |
Dow Chemical Co |
4-Alkyl-2,5-dimethoxy-alpha-methyl-phenaethylamin und seine pharmakologisch vertraeglichen Salze
|
US4099012A
(en)
|
1975-08-28 |
1978-07-04 |
Ciba-Geigy Corporation |
2-pyrazolyl-benzophenones
|
DE2926517A1
(de)
|
1979-06-30 |
1981-01-15 |
Beiersdorf Ag |
Substituierte 3-aryl-pyrazole und 5-aryl-isoxazole und verfahren zu ihrer herstellung
|
DE2928485A1
(de)
|
1979-07-14 |
1981-01-29 |
Bayer Ag |
Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
|
IL61721A
(en)
|
1980-12-16 |
1984-03-30 |
Blank Izhak |
Nitroglycerin preparations
|
US4555399A
(en)
|
1983-11-18 |
1985-11-26 |
Key Pharmaceuticals, Inc. |
Aspirin tablet
|
US4985352A
(en)
|
1988-02-29 |
1991-01-15 |
The Trustees Of Columbia University In The City Of New York |
DNA encoding serotonin 1C (5HT1c) receptor, isolated 5HT1c receptor, mammalian cells expressing same and uses thereof
|
IT1227626B
(it)
|
1988-11-28 |
1991-04-23 |
Vectorpharma Int |
Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
|
JPH03135978A
(ja)
|
1989-08-08 |
1991-06-10 |
Merck Sharp & Dohme Ltd |
置換ピリジン、その製法、処方並びに痴呆症における使用法
|
US5661024A
(en)
|
1989-10-31 |
1997-08-26 |
Synaptic Pharmaceutical Corporation |
DNA encoding a human serotonic (5-HT2) receptor and uses thereof
|
US5077409A
(en)
|
1990-05-04 |
1991-12-31 |
American Cyanamid Company |
Method of preparing bis-aryl amide and urea antagonists of platelet activating factor
|
US5128351A
(en)
|
1990-05-04 |
1992-07-07 |
American Cyanamid Company |
Bis-aryl amide and urea antagonists of platelet activating factor
|
JPH04334357A
(ja)
|
1991-05-02 |
1992-11-20 |
Fujirebio Inc |
酵素阻害作用を有するアシル誘導体
|
FR2682379B1
(fr)
|
1991-10-09 |
1994-02-11 |
Rhone Poulenc Agrochimie |
Nouveaux phenylpyrazoles fongicides.
|
FR2690440B1
(fr)
|
1992-04-27 |
1995-05-19 |
Rhone Poulenc Agrochimie |
Arylpyrazoles fongicides.
|
WO1995006044A1
(en)
|
1993-08-20 |
1995-03-02 |
Smithkline Beecham Plc |
Amide and urea derivatives as 5ht1d receptor antagonists
|
FR2722369B1
(fr)
|
1994-07-13 |
1998-07-10 |
Rhone Poulenc Agrochimie |
Compositions fongicides a base de derives 3-phenyl-pyrazoles pour le traitement du materiel vegetal de multiplication, nouveaux derives 3-phenyl-pyrazoles et leurs applications fongicides
|
KR970706242A
(ko)
|
1994-10-04 |
1997-11-03 |
후지야마 아키라 |
우레아 유도체 및 ACAT-억제제로서 그의 용도(Urea derivatives and their use as ACAT-inhibitors)
|
CA2135253A1
(en)
|
1994-11-07 |
1996-05-08 |
Michael Dennis |
Compound screening based on a window of chemical-messenger-independent activity
|
US6540981B2
(en)
|
1997-12-04 |
2003-04-01 |
Amersham Health As |
Light imaging contrast agents
|
EA000304B1
(ru)
|
1995-02-02 |
1999-04-29 |
Смитклайн Бичам Плс |
Производные индола как антагонисты рецептора 5-ht
|
JPH11503110A
(ja)
|
1995-02-17 |
1999-03-23 |
スミスクライン・ビーチャム・コーポレイション |
Il−8受容体拮抗剤
|
US5856326A
(en)
|
1995-03-29 |
1999-01-05 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
EP0822808B1
(en)
|
1995-04-20 |
2000-07-26 |
Eurand International S.P.A. |
Composite with sodium starch glycolate as a support material and products thereof
|
US5861431A
(en)
|
1995-06-07 |
1999-01-19 |
Iotek, Inc. |
Incontinence treatment
|
AU6526896A
(en)
|
1995-07-22 |
1997-02-18 |
Rhone-Poulenc Rorer Limited |
Substituted aromatic compounds and their pharmaceutical use
|
US6054472A
(en)
|
1996-04-23 |
2000-04-25 |
Vertex Pharmaceuticals, Incorporated |
Inhibitors of IMPDH enzyme
|
US6005008A
(en)
|
1996-02-16 |
1999-12-21 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
GB9607219D0
(en)
|
1996-04-04 |
1996-06-12 |
Smithkline Beecham Plc |
Novel compounds
|
JP2000510862A
(ja)
|
1996-05-24 |
2000-08-22 |
ニューロサーチ・アクティーゼルスカブ |
クロライドチャンネル遮断剤として有用なフエニル誘導体
|
AU735545B2
(en)
|
1996-05-24 |
2001-07-12 |
Neurosearch A/S |
Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
|
PL330849A1
(en)
|
1996-06-27 |
1999-06-07 |
Smithkline Beecham Corp |
Antagonists of il-8 receptors
|
WO1998000016A1
(en)
|
1996-07-01 |
1998-01-08 |
Sepracor, Inc. |
Methods and compositions for treating urinary incontinence using enantiomerically enriched (r,r)-glycopyrrolate
|
WO1998000133A1
(en)
|
1996-07-01 |
1998-01-08 |
Sepracor, Inc. |
Methods and compositions for treating urinary incontinence using enantiomerically enriched (s,s)-glycopyrrolate
|
AU721653B2
(en)
|
1996-10-25 |
2000-07-13 |
Supernus Pharmaceuticals, Inc. |
Soluble form osmotic dose delivery system
|
JP2001508767A
(ja)
|
1996-12-02 |
2001-07-03 |
藤沢薬品工業株式会社 |
5―ht拮抗作用を有するインドール―ウレア誘導体
|
US6420541B1
(en)
|
1998-04-14 |
2002-07-16 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
|
US6541209B1
(en)
|
1997-04-14 |
2003-04-01 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
|
US6696475B2
(en)
|
1997-04-22 |
2004-02-24 |
Neurosearch A/S |
Substituted phenyl derivatives, their preparation and use
|
BR9808938A
(pt)
|
1997-04-22 |
2000-08-01 |
Neurosearch As |
Composto, composição farmacêutica, uso de um composto, processos para o tratamento de um distúrbio ou doença de um corpo de animal vivo e para a preparação de um composto, e, uso de bloqueadores de canal de cloreto
|
US6028083A
(en)
|
1997-07-25 |
2000-02-22 |
Hoechst Marion Roussel, Inc. |
Esters of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
|
JP2001512096A
(ja)
|
1997-07-29 |
2001-08-21 |
スミスクライン・ビーチャム・コーポレイション |
Il−8レセプターアンタゴニスト
|
WO1999009988A1
(en)
|
1997-08-27 |
1999-03-04 |
Hexal Ag |
New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
|
CN1327443A
(zh)
|
1997-10-31 |
2001-12-19 |
艾文蒂斯药品有限公司 |
取代的酰苯胺化合物
|
JPH11183942A
(ja)
|
1997-12-19 |
1999-07-09 |
Nippon Mitsubishi Oil Corp |
エレクトロクロミック素子
|
US7517880B2
(en)
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
TR200100874T2
(tr)
|
1997-12-22 |
2001-06-21 |
Bayer Corporation |
Simetrik ve simetrik olmayan sübstitüe edilmiş difenil üreler kullanılarak raf kinazın inhibe edilmesi
|
EP1042305B1
(en)
|
1997-12-22 |
2005-06-08 |
Bayer Pharmaceuticals Corp. |
INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
|
US6107324A
(en)
|
1998-04-14 |
2000-08-22 |
Arena Pharmaceuticals Inc. |
5-HT2A receptor inverse agonists
|
US6140509A
(en)
|
1998-06-26 |
2000-10-31 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
|
GB9816263D0
(en)
|
1998-07-24 |
1998-09-23 |
Merck Sharp & Dohme |
Therapeutic agents
|
US6358698B1
(en)
|
1998-10-07 |
2002-03-19 |
Acadia Pharmacueticals Inc. |
Methods of identifying inverse agonists of the serotonin 2A receptor
|
AU759275B2
(en)
|
1998-10-22 |
2003-04-10 |
Neurosearch A/S |
Substituted phenyl derivatives, their preparation and use
|
US6150393A
(en)
|
1998-12-18 |
2000-11-21 |
Arena Pharmaceuticals, Inc. |
Small molecule modulators of non-endogenous, constitutively activated human serotonin receptors
|
US6180138B1
(en)
|
1999-01-29 |
2001-01-30 |
Abbott Laboratories |
Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
|
EP1173169B1
(en)
|
1999-03-26 |
2010-05-12 |
Euro-Celtique S.A. |
Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
|
GB9909409D0
(en)
|
1999-04-24 |
1999-06-23 |
Zeneca Ltd |
Chemical compounds
|
US6469006B1
(en)
|
1999-06-15 |
2002-10-22 |
Bristol-Myers Squibb Company |
Antiviral indoleoxoacetyl piperazine derivatives
|
IT1312115B1
(it)
|
1999-06-24 |
2002-04-04 |
Nicox Sa |
Composti amorfi e relative composizioni farmaceutiche
|
EE200200045A
(et)
|
1999-07-28 |
2003-06-16 |
Aventis Pharmaceuticals Products Inc. |
Asendatud oksoasaheterotsüklüülühendid, farmatseutiline kompositsioon ja vaheühendid
|
US6541477B2
(en)
|
1999-08-27 |
2003-04-01 |
Scios, Inc. |
Inhibitors of p38-a kinase
|
WO2001021160A2
(en)
|
1999-09-23 |
2001-03-29 |
Axxima Pharmaceuticals Aktiengesellschaft |
Carboxymide and aniline derivatives as selective inhibitors of pathogens
|
US6531291B1
(en)
|
1999-11-10 |
2003-03-11 |
The Trustees Of Columbia University In The City Of New York |
Antimicrobial activity of gemfibrozil and related compounds and derivatives and metabolites thereof
|
EP1108720A1
(en)
|
1999-12-08 |
2001-06-20 |
Basf Aktiengesellschaft |
Herbicidal 2-Pyrazolyl-6-Aryloxy-Pyri(mi)dines
|
EP1248770A1
(en)
|
1999-12-16 |
2002-10-16 |
Biostream Therapeutics |
1,3,4-substituted piperidine analogs and uses thereof in treating addictions
|
EP1242398A2
(en)
|
1999-12-20 |
2002-09-25 |
Neuromed Technologies, Inc. |
Partially saturated calcium channel blockers
|
WO2001064676A2
(en)
|
2000-02-28 |
2001-09-07 |
Scios, Inc. |
INHIBITORS OF p38-α KINASE
|
FR2810979B1
(fr)
|
2000-06-29 |
2002-08-23 |
Adir |
Nouveaux derives de diphenyluree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
GB0021885D0
(en)
|
2000-09-06 |
2000-10-18 |
Fujisawa Pharmaceutical Co |
New use
|
WO2002039987A2
(en)
|
2000-11-14 |
2002-05-23 |
Neurosearch A/S |
Use of malaria parasite anion channel blockers for treating malaria
|
AR035521A1
(es)
|
2000-12-22 |
2004-06-02 |
Lundbeck & Co As H |
Derivados de 3-indolina y composicion farmaceutica que los comprende
|
EP1351936A1
(en)
|
2001-01-15 |
2003-10-15 |
Glaxo Group Limited |
Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
|
US20020156068A1
(en)
|
2001-03-22 |
2002-10-24 |
Behan Dominic P. |
Anti-psychosis combination
|
EP1414414B1
(en)
|
2001-06-29 |
2007-11-07 |
Eurand Pharmaceuticals Ltd. |
Process of thermodynamical activation of water-insoluble drugs loaded into cross-linked polymers
|
JP4733877B2
(ja)
|
2001-08-15 |
2011-07-27 |
富士通セミコンダクター株式会社 |
半導体装置
|
PL204263B1
(pl)
|
2001-09-21 |
2009-12-31 |
Bristol Myers Squibb Co |
Pochodna 1H-pirazolo[3,4-c]pirydyny i jej zastosowanie oraz kompozycja farmaceutyczna i jej zastosowanie
|
WO2003062206A2
(en)
|
2002-01-23 |
2003-07-31 |
Arena Pharmaceuticals, Inc. |
Small molecule modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
|
US6743864B2
(en)
|
2002-03-12 |
2004-06-01 |
Basell Poliolefine Italia S.P.A. |
Polyolefin compositions having high tenacity
|
AU2003298514A1
(en)
|
2002-05-17 |
2004-05-04 |
Eisai Co., Ltd. |
Methods and compositions using cholinesterase inhibitors
|
WO2004028450A2
(en)
|
2002-09-24 |
2004-04-08 |
Arena Pharmaceuticals, Inc. |
Process of making phenylpyrazoles useful as selective 5ht2a modulators and intermediates thereof
|
US7635709B2
(en)
|
2002-09-26 |
2009-12-22 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Compositions and methods for bowel care in individuals with chronic intestinal pseudo-obstruction
|
TW200735568A
(en)
|
2002-11-08 |
2007-09-16 |
Interdigital Tech Corp |
Composite channel quality estimation techniques for wireless receivers
|
AU2003284402A1
(en)
|
2002-11-15 |
2004-06-15 |
Yamanouchi Pharmaceutical Co., Ltd. |
Antagonist to melanin-concentrating hormone receptor
|
US20060229335A1
(en)
|
2002-12-24 |
2006-10-12 |
Bradley Teegarden |
Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a
|
NZ541146A
(en)
|
2003-01-16 |
2009-04-30 |
Acadia Pharm Inc |
N-(1-methylpiperidin-4-yl)-N-(4-fluorophenylmethyl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide, also known as ACP-103, and its tartrate salt as therapeutics for neurodegenerative diseases
|
WO2004071426A2
(en)
|
2003-02-11 |
2004-08-26 |
Kemia Inc. |
Compounds for the treatment of viral infection
|
BRPI0408815A
(pt)
|
2003-03-28 |
2006-04-04 |
Pharmacia & Upjohn Co Llc |
moduladores alostéricos positivos do receptor nicotìnico da acetilcolina
|
GB0309781D0
(en)
|
2003-04-29 |
2003-06-04 |
Glaxo Group Ltd |
Compounds
|
EP1695966A1
(en)
|
2003-07-22 |
2006-08-30 |
Arena Pharmaceuticals, Inc. |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
|
EP1558582B1
(en)
*
|
2003-07-22 |
2005-12-21 |
Arena Pharmaceuticals, Inc. |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
|
JP2005046121A
(ja)
*
|
2003-07-31 |
2005-02-24 |
Japan Science & Technology Agency |
オンチップバイオアッセイ方法及びキット
|
MXPA06001636A
(es)
|
2003-08-13 |
2006-04-28 |
Amgen Inc |
Antagonista del receptor de la hormona concentradora de melanina.
|
US7091236B1
(en)
|
2003-08-20 |
2006-08-15 |
Sciele Pharma, Inc. |
Method for increasing the bioavailability of glycopyrrolate
|
US20050054691A1
(en)
|
2003-08-29 |
2005-03-10 |
St. Jude Children's Research Hospital |
Carboxylesterase inhibitors
|
WO2005021545A1
(en)
|
2003-09-03 |
2005-03-10 |
Galapagos Nv |
IMIDAZO[1,5-a]PYRIDINE OR IMIDAZO[1,5-a]PIPERIDINE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF MEDICAMENT AGAINST 5-HT2A RECEPTOR-RELATED DISORDERS
|
WO2005077345A1
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Compounds for the treatment of gastro-esophageal reflux disease
|
US20070293539A1
(en)
|
2004-03-18 |
2007-12-20 |
Lansbury Peter T |
Methods for the treatment of synucleinopathies
|
ATE548353T1
(de)
|
2004-03-23 |
2012-03-15 |
Arena Pharm Inc |
Verfahren zur herstellung von substituierte n- aryl-n'-ä3-(1h-pyrazol-5-yl)phenylü-harnstoffe and intermediate davon.
|
WO2006004722A2
(en)
|
2004-06-30 |
2006-01-12 |
Biomol Research Laboratories, Inc. |
Compositions and methods for selectively activating human sirtuins
|
US20060172992A1
(en)
|
2004-08-13 |
2006-08-03 |
Eisai Co., Ltd. |
Therapeutic agent for overactive bladder resulting from cerebral infarction
|
US20080261952A1
(en)
|
2004-08-16 |
2008-10-23 |
Jason Bloxham |
Aryl Urea Derivatives for Treating Obesity
|
US20060063754A1
(en)
|
2004-09-21 |
2006-03-23 |
Edgar Dale M |
Methods of treating a sleep disorder
|
WO2006045010A2
(en)
|
2004-10-20 |
2006-04-27 |
Resverlogix Corp. |
Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
|
CA2575764A1
(en)
|
2004-10-27 |
2006-05-11 |
Neurogen Corporation |
Diaryl ureas as cb1 antagonists
|
WO2006049734A2
(en)
|
2004-10-29 |
2006-05-11 |
Hypnion, Inc. |
Quetiapine analogs and methods of use thereof
|
WO2006050165A2
(en)
|
2004-11-01 |
2006-05-11 |
Seo Hong Yoo |
Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
|
SA05260357B1
(ar)
|
2004-11-19 |
2008-09-08 |
ارينا فارماسيتو تيكالز ، أنك |
مشتقات 3_فينيل_بيرازول كمعدلات لمستقبل سيروتينين 5_ht2a مفيدة في علاج الاضطرابات المتعلقه به
|
WO2006060654A2
(en)
|
2004-12-01 |
2006-06-08 |
Divergence, Inc. |
Pesticidal compositions and methods
|
GB0426313D0
(en)
|
2004-12-01 |
2005-01-05 |
Merck Sharp & Dohme |
Therapeutic agents
|
WO2006060762A2
(en)
|
2004-12-03 |
2006-06-08 |
Arena Pharmaceuticals, Inc. |
Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
DE102004061593A1
(de)
|
2004-12-21 |
2006-06-22 |
Abbott Gmbh & Co. Kg |
Substituierte N-heterocyclische Verbindungen und ihre therapeutische Verwendung
|
EP1831172B1
(en)
|
2004-12-28 |
2009-02-18 |
Council of Scientific and Industrial Research |
Substituted carbamic acid quinolin-6-yl esters useful as acetylcholinesterase inhibitors
|
ES2465469T3
(es)
|
2005-01-14 |
2014-06-05 |
Gilead Connecticut, Inc. |
Diaril ureas 1,3-sustituidas como moduladores de la actividad quinasa
|
US20080200530A1
(en)
|
2005-01-19 |
2008-08-21 |
Unett David J |
Diaryl and Arylheteroaryl Urea Derivatives as Modulators of 5-Ht2a Serotonin Receptor Useful for the Prophylaxis or Treatment of Progressive Multifocal Leukoencephalopathy
|
CA2595483A1
(en)
|
2005-01-21 |
2006-07-27 |
Teva Pharmaceutical Industries Ltd. |
Stable pharmaceutical formulations of zonisamide and methods for their manufacture
|
AR052886A1
(es)
|
2005-01-26 |
2007-04-11 |
Arena Pharm Inc |
Procedimientos para preparar fenilpirazol ureas sustituidas y para la obtencion de sus intermediarios de sintesis
|
US7915249B2
(en)
|
2005-01-27 |
2011-03-29 |
Janssen Pharmaceutical Nv |
Heterocyclic tetracyclic tetrahydrofuran derivatives as 5HT2 inhibitors in the treatment of CNS disorders
|
GT200600042A
(es)
|
2005-02-10 |
2006-09-27 |
Aventis Pharma Inc |
Compuestos de bis arilo y heteroarilo sustituido como antagonistas selectivos de 5ht2a
|
WO2006089871A2
(en)
|
2005-02-23 |
2006-08-31 |
Neurosearch A/S |
Diphenylurea derivatives useful as erg channel openers for the treatment of cardiac arrhythmias
|
GB0504828D0
(en)
|
2005-03-09 |
2005-04-13 |
Merck Sharp & Dohme |
Therapeutic agents
|
GB0505437D0
(en)
|
2005-03-17 |
2005-04-20 |
Merck Sharp & Dohme |
Therapeutic agents
|
GB0505725D0
(en)
|
2005-03-19 |
2005-04-27 |
Merck Sharp & Dohme |
Therapeutic agents
|
TWI320783B
(en)
|
2005-04-14 |
2010-02-21 |
Otsuka Pharma Co Ltd |
Heterocyclic compound
|
EP1877405B1
(en)
|
2005-04-26 |
2010-03-03 |
Hypnion, Inc. |
Benzisoxazole piperidine compounds and methods of use thereof
|
EP1734039A1
(en)
|
2005-06-13 |
2006-12-20 |
Esbatech AG |
Aryl urea compounds as BETA-secretase inhibitors
|
SG162804A1
(en)
|
2005-06-27 |
2010-07-29 |
Exelixis Inc |
Pyrazole based lxr modulators
|
US7754724B2
(en)
|
2005-06-30 |
2010-07-13 |
Dow Agrosciences Llc |
N-substituted piperazines
|
US8093401B2
(en)
|
2005-08-04 |
2012-01-10 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
US7544685B2
(en)
|
2005-08-17 |
2009-06-09 |
H. Lundbeck A/S |
2,3-dihydroindole compounds
|
AR055203A1
(es)
|
2005-08-31 |
2007-08-08 |
Otsuka Pharma Co Ltd |
Derivados de benzotiofeno con propiedades antipsicoticas
|
KR20080055963A
(ko)
|
2005-09-29 |
2008-06-19 |
아레나 파마슈티칼스, 인크. |
5-ht2a 세로토닌 수용체 조절제와 관련된 장애의 치료에유용한 5-ht2a 세로토닌 수용체 조절제의 제약 조성물
|
EP2004627A2
(en)
|
2006-04-10 |
2008-12-24 |
Arena Pharmaceuticals, Inc. |
3-pyridinyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
GB0608655D0
(en)
|
2006-05-03 |
2006-06-14 |
Merck Sharp & Dohme |
Therapeutic Treatment
|
WO2007136875A2
(en)
|
2006-05-18 |
2007-11-29 |
Arena Pharmaceuticals, Inc. |
Acetamide derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
EP2018371B1
(en)
|
2006-05-18 |
2015-03-04 |
Arena Pharmaceuticals, Inc. |
Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
CA2646076C
(en)
|
2006-05-18 |
2015-06-30 |
Arena Pharmaceuticals, Inc. |
Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
WO2007136689A2
(en)
|
2006-05-18 |
2007-11-29 |
Arena Pharmaceuticals, Inc. |
Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor
|
WO2008027483A1
(en)
|
2006-08-31 |
2008-03-06 |
Arena Pharmaceuticals, Inc. |
Benzofuran derivatives as modulators of the 5-ht2a receptor
|
TWI415845B
(zh)
|
2006-10-03 |
2013-11-21 |
Arena Pharm Inc |
用於治療與5-ht2a血清素受體相關聯病症之作為5-ht2a血清素受體之調節劑的吡唑衍生物
|
TW200823204A
(en)
|
2006-10-17 |
2008-06-01 |
Arena Pharm Inc |
Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine H3-receptor useful for the treatment of disorders related thereto
|
WO2008054748A2
(en)
|
2006-10-31 |
2008-05-08 |
Arena Pharmaceuticals, Inc. |
Indazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
US9034890B2
(en)
|
2006-11-15 |
2015-05-19 |
Steven A. Rich |
Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases
|
US8969402B2
(en)
|
2006-11-15 |
2015-03-03 |
Steven A. Rich |
Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases
|
US8097633B2
(en)
|
2006-11-15 |
2012-01-17 |
Rich Steven A |
Uses for quaternary ammonium anticholinergic muscarinic receptor antagonists in patients being treated for cognitive impairment or acute delirium
|
EP2121621B1
(en)
|
2006-12-08 |
2014-05-07 |
Exelixis Patent Company LLC |
Lxr and fxr modulators
|
US9567327B2
(en)
|
2007-08-15 |
2017-02-14 |
Arena Pharmaceuticals, Inc. |
Imidazo[1,2-a]pyridine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
|
US20090082388A1
(en)
|
2007-09-21 |
2009-03-26 |
Acadia Pharmaceuticals Inc. |
Co-administration of pimavanserin with other agents
|
US9084742B2
(en)
|
2007-12-12 |
2015-07-21 |
Axovant Sciences Ltd. |
Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-Quinoline
|
WO2009123714A2
(en)
|
2008-04-02 |
2009-10-08 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
|
US9034911B2
(en)
|
2008-10-28 |
2015-05-19 |
Arena Pharmaceuticals, Inc. |
Composition of a 5-HT2A serotonin receptor modulator useful for the treatment of disorders related thereto
|
WO2010062321A1
(en)
|
2008-10-28 |
2010-06-03 |
Arena Pharmaceuticals, Inc. |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
|
GB201111712D0
(en)
|
2011-07-08 |
2011-08-24 |
Gosforth Ct Holdings Pty Ltd |
Pharmaceutical compositions
|
KR20150017763A
(ko)
|
2012-06-11 |
2015-02-17 |
싸이코제닉스 아이엔씨. |
파킨슨병 치료와 관련된 운동 장애 부작용의 치료
|
JOP20210047A1
(ar)
|
2012-10-25 |
2017-06-16 |
Otsuka Pharma Co Ltd |
عامل وقائي و/أو علاجي للأعراض السلوكية والنفسية المصحوبة بمرض تنكسي عصبي أو الأعراض الإندفاعية المصحوبة بمرض ذهني، يحتوي على بريكسبيرازول أو ملحه
|
US9446037B2
(en)
|
2012-11-27 |
2016-09-20 |
Acadia Pharmaceuticals Inc. |
Methods for the treatment of parkinson's disease psychosis using pimavanserin
|
KR101472682B1
(ko)
|
2013-07-23 |
2014-12-15 |
고려대학교 산학협력단 |
메타물질 제조 방법, 이에 의해 제조된 메타물질 구조 필름 및 이를 이용한 광학 이미징 시스템
|
HUE056496T2
(hu)
|
2013-12-03 |
2022-02-28 |
Intra Cellular Therapies Inc |
Eljárás skizofrénia reziduális szimptómáinak kezelésére
|
WO2015171547A1
(en)
|
2014-05-05 |
2015-11-12 |
Ovid Therapeutics Inc. |
Methods of treating cognitive impairment associated with neurodegenerative disorders
|
KR20180022792A
(ko)
|
2015-06-12 |
2018-03-06 |
엑소반트 사이언시즈 게엠베하 |
렘 수면 행동 장애의 예방 및 치료에 유용한 디아릴 및 아릴헤테로아릴 우레아 유도체
|
CN108472285A
(zh)
|
2015-07-15 |
2018-08-31 |
阿速万科学有限责任公司 |
用于预防和治疗与神经退行性疾病相关联的幻觉的二芳基和芳基杂芳基脲衍生物
|
WO2018148737A1
(en)
|
2017-02-13 |
2018-08-16 |
Axovant Sciences Gmbh |
5-ht2a serotonin receptor serotonin receptor inverse agonists useful for the prophylaxis and treatment of parkinsonian symptoms associated with a neurodegenerative disease
|
US20190046506A1
(en)
|
2017-08-10 |
2019-02-14 |
Axovant Sciences Gmbh |
Use of 5ht2a inverse agonists for treating psychosis
|